« Back to Record
Citation APA

Bines, J., Procter, M., Restuccia, E., Viale, G., Zardavas, D., Suter, T., Arahmani, A., van Dooren, V., Baselga, J., Clark, E., Eng-Wong, J., Gelber, R., Piccart-Gebhart, M., Mobus, V., & de Azambuja, E. (2020). Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. Clinical breast cancer. doi:10.1016/j.clbc.2019.06.016


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/301693

Bines, J., Procter, M., Restuccia, E., Viale, G., Zardavas, D., Suter, T., Arahmani, A., van Dooren, V., Baselga, J., Clark, E., Eng-Wong, J., Gelber, R., Piccart-Gebhart, M., Mobus, V., & de Azambuja, E. (2020). Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. Clinical breast cancer. doi:10.1016/j.clbc.2019.06.016